An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Using advanced gene targeting methods, generating mouse models of cancer that accurately reproduce the genetic alterations present in human tumors is now relatively straightforward. The challenge is to determine to what extent such models faithfully mimic human disease with respect to the underlying molecular mechanisms that accompany tumor progression. Here we describe a method for comparing mouse models of cancer with human tumors using gene-expression profiling. We applied this method to the analysis of a model of Kras2-mediated lung cancer and found a good relationship to human lung adenocarcinoma, thereby validating the model. Furthermore, we found that whereas a gene-expression signature of KRAS2 activation was not identifiable when analyzing human tumors with known KRAS2 mutation status alone, integrating mouse and human data uncovered a gene-expression signature of KRAS2 mutation in human lung cancer. We confirmed the importance of this signature by gene-expression analysis of short hairpin RNA-mediated inhibition of oncogenic Kras2. These experiments identified both a pattern of gene expression indicative of KRAS2 mutation and potential effectors of oncogenic KRAS2 activity in human cancer. This approach provides a strategy for using genomic analysis of animal models to probe human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p-Values are adjusted to account for multiple hypothesis testing [34].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [34]
Citations
Cites
Wu, Y. (1999) · Technometrics · doi:10.1080/00401706.1999.10485951 · Cited by 27,221
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationDalapicolla, J., do Prado, J. R., Percequillo, A. R., & Knowles, L. L. (2021) · Journal of Biogeography · doi:10.1111/jbi.14281 · Cited by 11,461
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“The importance of limiting ERK signaling in Ras-induced tumorigenesis is suggested by the facts that overexpression of Ras in vitro causes cellular senescence and that this effect is mediated by the MAPK pathwa”
BackgroundBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Self-citationA molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Self-citation
Cited by
Items 201–300 of 404
Calvisi, D. F., Frau, M., Tomasi, M. L., Feo, F., & Pascale, R. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.003 · Cited by 45
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Valencia, K., Erice, O., Kostyrko, K., Hausmann, S., Guruceaga, E., Tathireddy, A., Flores, N. M., Sayles, L. C., Lee, A. G., Fragoso, R., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129012 · Cited by 45
Self-citationA New Generation of Mouse Models of Cancer for Translational Research
Abate-Shen, C. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0500 · Cited by 40
Martin, E. S., Belmont, P. J., Sinnamon, M. J., Richard, L. G., Yuan, J., Coffee, E. M., Roper, J., Lee, L., Heidari, P., Lunt, S. Y., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2307 · Cited by 37
Degrassi, A., Russo, M., Nanni, C., Patton, V., Alzani, R., Giusti, A. M., Fanti, S., Ciomei, M., Pesenti, E. A., & Texidó, G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0726 · Cited by 38
Keller, J. W., Franklin, J. L., Graves‐Deal, R., Friedman, D. B., Whitwell, C. W., & Coffey, R. J. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20898 · Cited by 37
Planck, M., Edlund, K., Botling, J., Micke, P., Isaksson, S., & Staaf, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078614 · Cited by 37
Perez, B. A., Ghafoori, A. P., Lee, C., Johnston, S. M., Li, Y., Moroshek, J. G., Ma, Y., Mukherjee, S., Kim, Y., Badea, C. T., et al. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00072 · Cited by 36
Self-citationSynergy of WEE1 and mTOR Inhibition in Mutant KRAS -Driven Lung Cancers
Hai, J., Liu, S., Bufe, L. E., Do, K. T., Chen, T., Wang, X., Ng, C., Li, S., Tsao, M., Shapiro, G. I., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1098 · Cited by 40
Kadara, H. N., Fujimoto, J., Men, T., Ye, X., Lotan, D., Lee, J., & Lotan, R. (2010) · Neoplasia · doi:10.1593/neo.10390 · Cited by 35
RAS and PKA pathways in cancer: new insight from transcriptional analysis
Chiaradonna, F., Balestrieri, C., Gaglio, D., & Vanoni, M. (2008) · Frontiers in bioscience · doi:10.2741/3079 · Cited by 43
Kim, S., Yun, S. J., Kim, J., Lee, O.-J., Bae, S., & Kim, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026131 · Cited by 34
Gracey, A. Y., & Connor, K. M. (2016) · Marine Genomics · doi:10.1016/j.margen.2016.07.004 · Cited by 34
Cheadle, C., Nesterova, M., Watkins, T., Barnes, K. C., Hall, J. C., Rosen, A., Becker, K. G., & Cho‐Chung, Y. S. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-43 · Cited by 41
Borczuk, A., Solé, M., Lü, P., Chen, J., Wilgus, M., Friedman, R. A., Albelda, S. Μ., & Powell, C. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1590 · Cited by 36
Çolak, D., Chishti, M. A., AlBakheet, A., Al-Qahtani, A. A., Shoukri, M. M., Goyns, M. H., Ozand, P. T., Quackenbush, J. F., Park, B. H., & Kaya, N. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-146 · Cited by 36
Kobayashi, I., Ono, H., Moritomo, T., Kano, K., Nakanishi, T., & Suda, T. (2009) · Blood · doi:10.1182/blood-2009-07-232322 · Cited by 37
Lung Cancer Genomic Signatures
Agulló-Ortuño, M. T., López‐Ríos, F., & Paz-Ares, L. G. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f1900e · Cited by 36
Kucherlapati, M. H., Nguyen, A. A., Bronson, R. T., & Kucherlapati, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2699 · Cited by 33
Arena, S., Isella, C., Martini, M., de Marco, A., Medico, E., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1126 · Cited by 34
The rapamycin-regulated gene expression signature determines prognosis for breast cancer
Akçakanat, A., Zhang, L., Tsavachidis, S., & Meric‐Bernstam, F. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-75 · Cited by 32
Developing gene expression signatures of pathway deregulation in tumors
Watters, J., & Roberts, C. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0340 · Cited by 32
Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer
Beane, J., Spira, A. E., & Lenburg, M. E. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819151f8 · Cited by 33
Wu, B., Shang, H., Liang, X., Sun, Y., Jing, H., Han, X., & Cheng, W. (2019) · The FASEB Journal · doi:10.1096/fj.201900716rr · Cited by 31
Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells
Turner, S. D., & Alexander, D. R. (2006) · Leukemia · doi:10.1038/sj.leu.2404125 · Cited by 33
Hai, Y., Wei, Q., Zhong, X., Yang, H., & Li, B. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw662 · Cited by 32
Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer
Hijazo‐Pechero, S., Alay, A., Marín, R., Vilariño, N., Muñoz‐Pinedo, C., Villanueva, A., Santamaría, D., Nadal, E., & Solé, X. (2021) · Cancers · doi:10.3390/cancers13194734 · Cited by 35
PKC ϵ Is Required for KRAS-Driven Lung Tumorigenesis
Garg, R., Cooke, M., Wang, S., Benavides, F., Abba, M. C., Cicchini, M., Feldser, D. M., & Kazanietz, M. G. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1300 · Cited by 29
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
Maroni, G., Bassal, M. A., Krishnan, I., Fhu, C. W., Savova, V., Žilionis, R., Maymi, V. A., Pandell, N., Csizmadia, E., Zhang, J., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01897-6 · Cited by 29
Carrabotta, M., Laginestra, M. A., Durante, G., Mancarella, C., Landuzzi, L., Parra, A., Ruzzi, F., Toracchio, L., Feo, A. D., Giusti, V., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1222 · Cited by 31
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity
Murthy, P. K. L., Xi, R., Mendoza, D. A., Everitt, J. I., Koçak, D. D., Kobayashi, Y., Bözec, A., Vicent, S., Ding, S., Crawford, G. E., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.01.006 · Cited by 31
Expression Profiling and Lung Cancer Development
Borczuk, A., & Powell, C. A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200607-143jg · Cited by 33
Biomarkers Downstream of RAS: A Search for Robust Transcriptional Targets
Győrffy, B., & Schäfer, R. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357916 · Cited by 31
Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling
Sargent, J. L., & Whitfield, M. L. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.41 · Cited by 29
Abate-Shen, C. T., Brown, P. H., Colburn, N. H., Gerner, E. W., Green, J. E., Lipkin, M., Nelson, W. G., & Threadgill, D. W. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0076 · Cited by 29
Normalizing for individual cell population context in the analysis of high-content cellular screens
Knapp, B. L., Rebhan, I., Kumar, A., Matula, P., Kiani, N. A., Binder, M., Erfle, H., Rohr, K., Eils, R., Bartenschlager, R. F. W., et al. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-485 · Cited by 29
FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
Guo, Z., Yan, X., Song, C., Wang, Q., Wang, Y., Liu, X.-P., Huang, J., Li, S., & Hu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.603660 · Cited by 32
Zeliadt, N. A., Mauro, L. J., & Wattenberg, E. V. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.007 · Cited by 32
A rapid method for microarray cross platform comparisons using gene expression signatures
Cheadle, C., Becker, K. G., Cho‐Chung, Y. S., Nesterova, M., Watkins, T., Wood, W. H., Prabhu, V. V., & Barnes, K. C. (2006) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2006.07.004 · Cited by 28
Fishing for the origins of cancer: Figure 1.
Merlino, G. T., & Khanna, C. (2007) · Genes & Development · doi:10.1101/gad.1563707 · Cited by 29
Mining cancer gene expression databases for latent information on intronic microRNAs
Monterisi, S., D’Ario, G., Dama, E., Rotmensz, N., Confalonieri, S., Tordonato, C., Troglio, F., Bertalot, G., Maisonneuve, P., Viale, G., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.10.001 · Cited by 28
A mouse plasma peptide atlas as a resource for disease proteomics
Zhang, Q. H., Menon, R., Deutsch, E. W., Pitteri, S. J., Faça, V. M., Wang, H., Newcomb, L. F., DePinho, R. A., Bardeesy, N. M., Dinulescu, D. M., et al. (2008) · Genome biology · doi:10.1186/gb-2008-9-6-r93 · Cited by 27
Self-citationLung cancer: genetics of risk and advances in chemoprevention
Keith, R. L., & Miller, Y. E. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000166493.77412.2d · Cited by 29
Park, P. J., Kong, S. W., Tebaldi, T., Lai, W. R., Kasif, S., & Kohane, I. S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp559 · Cited by 29
Genetically engineered mouse models of diffuse gliomas
Schmid, R. S., Vitucci, M., & Miller, C. R. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.06.002 · Cited by 28
García‐Escudero, R., Martínez‐Cruz, A. B., Santos, M., Lorz, C., Segrelles, C., Garaulet, G., Sáiz-Ladera, C., Costa, C., Buitrago-Pérez, Á., Dueñas, M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-193 · Cited by 26
AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer
Tien, J. C.-Y., Chugh, S., Goodrum, A. E., Cheng, Y., Mannan, R., Zhang, Y., Wang, L., Dommeti, V. L., Wang, X., Xu, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026104118 · Cited by 28
Rattay, K., Meyer, H. V., Herrmann, C., Brors, B., & Kyewski, B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.10.001 · Cited by 40
RAS signalling in the colorectum in health and disease
Poulogiannis, G., Luo, F., & Arends, M. J. (2012) · Cell Communication & Adhesion · doi:10.3109/15419061.2011.649380 · Cited by 29
Grabher, C., & Look, A. T. (2006) · Nature Biotechnology · doi:10.1038/nbt0106-45 · Cited by 25
Wurz, G. T., Gutierrez, A. M., Greenberg, B. E., Vang, D. P., Griffey, S. M., Kao, C.-J., Wolf, M., & DeGregorio, M. W. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-64 · Cited by 24
Lakshmikuttyamma, A., Sun, Y., Lu, J., Undieh, A. S., & Shoyele, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500525p · Cited by 24
Gene Expression Analysis to Assess the Relevance of Rodent Models to Human Lung Injury
Sweeney, T. E., Lofgren, S., Khatri, P., & Rogers, A. J. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0395oc · Cited by 24
Smoking and Lung Cancer: Future Research Directions
Haussmann, H. (2007) · International Journal of Toxicology · doi:10.1080/10915810701490463 · Cited by 30
Toward the individualization of lung cancer therapy
Anguiano, A., Nevins, J. R., & Potti, A. (2008) · Cancer · doi:10.1002/cncr.23644 · Cited by 24
Liang, J., Li, Z.-W., Yue, C.-T., Hu, Z., Cheng, H., Liu, Z.-X., & Guo, W.-F. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac254 · Cited by 23
Novel strategies for managing pancreatic cancer
Loc, W. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14717 · Cited by 23
Dissecting the Transcriptional Patterns of Social Dominance across Teleosts
Renn, S. C. P., O’Rourke, C. F., Aubin‐Horth, N., Fraser, E. J., & Hofmann, H. A. (2016) · Integrative and Comparative Biology · doi:10.1093/icb/icw118 · Cited by 27
Identification of Candidate B-Lymphoma Genes by Cross-Species Gene Expression Profiling
Tompkins, V. S., Han, S., Olivier, A. K., Syrbu, S., Bair, T., Button, A. M., Jacobus, L., Wang, Z., Lifton, S., Raychaudhuri, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076889 · Cited by 25
Functional genomic analysis of cancer metastasis: biologic insights and clinical implications
Kang, Y. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.3.385 · Cited by 23
MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma
Salaün, M., Peng, J., Hensley, H. H., Roder, N. A., Flieder, D. B., Houlle, S., Abramovici-Roels, O., Sabourin, J., Thiberville, L., & Clapper, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132960 · Cited by 21
Pemov, A., Park, C., Reilly, K. M., & Stewart, D. R. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-194 · Cited by 21
Cancer gene discovery in mouse and man
Mattison, J., van der Weyden, L., Hubbard, T., & Adams, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.001 · Cited by 30
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
Ambrogio, C., Nadal, E., Villanueva, A., Goméz-López, G., Cash, T. P., Barbacid, M., & Santamaría, D. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000076 · Cited by 22
Cross-species comparisons of cancer signaling
Graeber, T. G., & Sawyers, C. L. (2004) · Nature Genetics · doi:10.1038/ng0105-7 · Cited by 21
Dennis, C. (2006) · Nature · doi:10.1038/442739a · Cited by 23
Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines
Uva, P., Lahm, A., Sbardellati, A., Grigoriadis, A. E., Tutt, A. N. J., & de Rinaldis, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011742 · Cited by 20
Gene expression profiling as a tool for basic analysis and clinical application of human cancer
García‐Escudero, R., & Paramio, J. M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20430 · Cited by 20
Yi, M., & Stephens, R. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003288 · Cited by 19
Gene set enrichment meta-learning analysis: next- generation sequencing versus microarrays
Štiglic, G., Bajgot, M., & Kokol, P. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-176 · Cited by 22
Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer
Du, S., Lockamy, V. L., Zhou, L., Xue, C., LeBlanc, J. M., Glenn, S., Shukla, G., Yu, Y., Dicker, A. P., Leeper, D. B., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.07.008 · Cited by 21
Kruse, J. J. C. M., Svensson, J. P., Huigsloot, M., Giphart-Gassler, M., Schoonen, W. G. E. J., Polman, J., Horbach, G. J., van de Water, B., & Vrieling, H. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.12.004 · Cited by 19
Castellano, E., Guerrero, C., Núñez, A., Rivas, J. D. L., & Santos, E. (2009) · Genome biology · doi:10.1186/gb-2009-10-11-r123 · Cited by 20
Noise and Bias in Microarray Analysis of Tumor Specimens
Febbo, P. G., & Kantoff, P. W. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7942 · Cited by 20
Zhu, M., Geng, L., Shen, W., Wang, Y., Liu, J., Yang, C., Wang, C., Dai, J., Jin, G., Hu, Z., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.12.025 · Cited by 19
Practical Use of Advanced Mouse Models for Lung Cancer
Safari, R., & Meuwissen, R. L. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_5 · Cited by 20
Taking Bioinformatics to Systems Medicine
van Kampen, A. H. C., & Moerland, P. D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3283-2_2 · Cited by 19
Zebrafish Models of Rhabdomyosarcoma
Chen, E. Y., & Langenau, D. M. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00016-3 · Cited by 21
A Computational Pipeline for Cross-Species Analysis of RNA-seq Data Using R and Bioconductor
LoVerso, P. R., & Cui, F. (2015) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s30884 · Cited by 19
Molecular Characterization of Lung Dysplasia Induced by c-Raf-1
Rohrbeck, A., Müller, V. S., & Borlak, J. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005637 · Cited by 16
Pathprinting: An integrative approach to understand the functional basis of disease
Altschuler, G. M., Hofmann, O., Kalatskaya, I., Payne, R., Sui, S. J. H., Saxena, U., Krivtsov, A. V., Armstrong, S. A., Cai, T., Stein, L. D., et al. (2013) · Genome Medicine · doi:10.1186/gm472 · Cited by 17
Shoushtari, A. N., Michalowska, A. M., & Green, J. E. (2007) · Breast Disease · doi:10.3233/bd-2007-28105 · Cited by 17
Abate-Shen, C. T., & Pandolfi, P. P. (2013) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top078774 · Cited by 19
Lung Adenocarcinomas: Comparison Between Mice and Men
Popper, H. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_2 · Cited by 15
Yousefi, M., Boross, G. Z., Weiss, C. V., Murray, C. W., Hebert, J. D., Cai, H., Ashkin, E. L., Karmakar, S., Andrejka, L., Chen, L. C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0059 · Cited by 15
Speen, A. M., Murray, J. R., Krantz, Q. T., Davies, D., Evansky, P., Harrill, J., Everett, L. J., Bundy, J. L., Dailey, L. A., Hill, J., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac040 · Cited by 15
Azrak, S., Ginel-Picardo, A., Drosten, M., Barbacid, M., & Santos, E. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-731 · Cited by 15
Liu, Z., Wang, M., Alvarez, J. V., Bonney, M., Chen, C.-C., D’Cruz, C. M., Pan, T.-C., Tadesse, M. G., & Chodosh, L. A. (2008) · Genome biology · doi:10.1186/gb-2008-9-12-r180 · Cited by 14
The Landscape of Somatic Chromosomal Copy Number Aberrations in GEM Models of Prostate Carcinoma
Bianchi-Frias, D., Hernández, S., COLEMAN, R. T., Wu, H., & Nelson, P. S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0262 · Cited by 15
Wakamatsu, N., Collins, J. B., Parker, J. S., Tessema, M., Clayton, N. P., Ton, T.-V. T., Hong, H. L., Belinsky, S. A., Devereux, T. R., Sills, R. C., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623308320801 · Cited by 14
Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung
Starmans, M. H. W., Pintilie, M., Chan‐Seng‐Yue, M., Moon, N. C., Haider, S., Nguyen, F., Lau, S. K., Liu, G., Kasprzyk, A., Wouters, B. G., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1749 · Cited by 13
The Zebrafish Model for Liver Carcinogenesis
Gong, Z., Koh, C. H. V., Nguyễn, A. T., Zhan, H., Li, Z., Lam, S. H., Spitsbergen, J. M., Emelyanov, A., & Parinov, S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6082-5_11 · Cited by 14
Taneera, J., Storm, P., & Groop, L. (2014) · Journal of Diabetes Research · doi:10.1155/2014/237535 · Cited by 14
Translational Therapeutics in Genetically Engineered Mouse Models of Cancer
Olive, K. P., & Politi, K. A. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069997 · Cited by 13
Renal Cell Carcinoma Deep Sequencing: Recent Developments
Farber, L. J., Furge, K., & Teh, B. T. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0230-3 · Cited by 14
Al‐Harazi, O., Kaya, I. H., Al-Eid, M., Alfantoukh, L., Al‐Zahrani, A., Sebayel, M. A., Kaya, N., & Çolak, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.710049 · Cited by 14
Baron, D., Raharijaona, M., & Houlgatte, R. (2007) · IRBM · doi:10.1016/j.rbmret.2007.11.010 · Cited by 12
Jia, R., Oda, S., Tsuneyama, K., Urano, Y., & Yokoi, T. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3838 · Cited by 11
C8orf48 inhibits the tumorigenesis of colorectal cancer by regulating the MAPK signaling pathway
Lei, L., An, G., Zhu, Z., Liu, S., Fu, Y., Zeng, X., Cao, Q., & Yan, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118872 · Cited by 10
cDNA microarray analysis of esophageal cancer: discoveries and prospects
Shimada, Y., Sato, F., Shimizu, K., Tsujimoto, G., & Tsukada, K. (2009) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-008-0406-9 · Cited by 10
Metadata
- Authors
- Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T.
- Affiliations
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Jacks, Tyler
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-12-19
- Volume
- 37
- Issue
- 1
- Pages
- 48-55
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2111476798
- Cited by
- 414
- References
- 38
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 16 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 12 · 2015: 18 · 2014: 14 · 2013: 25 · 2012: 29
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- KRAS2, oncogenic KRAS, gene expression signatures, mouse tumor model, lung adenocarcinoma, KRAS mutation, shRNA, gene expression profiling, tumor progression, model validation
- MeSH terms
- Adenocarcinoma, Animals, Lung Neoplasms, Proto-Oncogene Proteins, Species Specificity, Gene Expression, Proto-Oncogene Proteins p21(ras), ras Proteins, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.